Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Peloton Therapeutics
Peloton Therapeutics
Asco-GU 2020: revving up for Peloton deal validation
Asco-GU 2020: revving up for Peloton deal validation
EP Vantage
ASCO-GU 2020
Merck
Peloton Therapeutics
Exelixis
Flag link:
Merck puts $1B more into oncology, with kidney cancer a focus
Merck puts $1B more into oncology, with kidney cancer a focus
Biopharma Dive
Merck
kidney cancer
M&A
Peloton Therapeutics
Flag link:
Merck boosts late-phase cancer pipeline with $1.1B Peloton buy
Merck boosts late-phase cancer pipeline with $1.1B Peloton buy
Fierce Biotech
Merck
M&A
Peloton Therapeutics
metastatic renal cell carcinoma
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Incyte
Novartis
Athersys
ResTORbio
Bellerophon Therapeutics
Eli Lilly
CymaBay
Bicycle Therapeutics
Peloton Therapeutics
Ideaya
IPOs
Flag link:
Peloton Therapeutics Initiates Phase II Trials of Treatment for Rare Kidney Cancer
Peloton Therapeutics Initiates Phase II Trials of Treatment for Rare Kidney Cancer
CP Wire
Peloton Therapeutics
renal cell carcinoma
PT2977
Flag link:
Peloton Therapeutics Initiates Phase II Trials of Treatment for Rare Kidney Cancer
Peloton Therapeutics
renal cell carcinoma
PT2977
Flag link:
